ASX:AJJ

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Asian American Medical Group

Market Cap

AU$11.8m

Last Updated

2021/06/24 17:00 UTC

Data Sources

Company Financials

Executive Summary

Asian American Medical Group Limited provides specialized medical services for liver diseases in Singapore, rest of Asia, and internationally. More Details


Snowflake Analysis

Excellent balance sheet and overvalued.

Share Price & News

How has Asian American Medical Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: Insufficient data to determine AJJ's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine AJJ's volatility change over the past year.


Market Performance


7 Day Return

0%

AJJ

-0.6%

AU Healthcare

-1.5%

AU Market


1 Year Return

n/a

AJJ

15.7%

AU Healthcare

28.1%

AU Market

Return vs Industry: Insufficient data to determine how AJJ performed against the Australian Healthcare industry.

Return vs Market: Insufficient data to determine how AJJ performed against the Australian Market.


Shareholder returns

AJJIndustryMarket
7 Day0%-0.6%-1.5%
30 Day-10.5%3.3%2.4%
90 Dayn/a0.2%6.3%
1 Yearn/a17.8%15.7%32.2%28.1%
3 Year-67.6%-67.6%35.9%25.2%31.6%16.3%
5 Year-66.0%-66.0%27.8%11.1%66.2%34.7%

Long-Term Price Volatility Vs. Market

How volatile is Asian American Medical Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Asian American Medical Group undervalued compared to its fair value and its price relative to the market?

1.27x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate AJJ's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate AJJ's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: AJJ is unprofitable, so we can't compare its PE Ratio to the Australian Healthcare industry average.

PE vs Market: AJJ is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AJJ's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AJJ is good value based on its PB Ratio (1.3x) compared to the AU Healthcare industry average (1.7x).


Future Growth

How is Asian American Medical Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

2.4%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Asian American Medical Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Asian American Medical Group performed over the past 5 years?

-3.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AJJ is currently unprofitable.

Growing Profit Margin: AJJ is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: AJJ is unprofitable, and losses have increased over the past 5 years at a rate of 3.6% per year.

Accelerating Growth: Unable to compare AJJ's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AJJ is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (25.5%).


Return on Equity

High ROE: AJJ has a negative Return on Equity (-29.73%), as it is currently unprofitable.


Financial Health

How is Asian American Medical Group's financial position?


Financial Position Analysis

Short Term Liabilities: AJJ's short term assets (SGD1.6M) do not cover its short term liabilities (SGD2.1M).

Long Term Liabilities: AJJ's short term assets (SGD1.6M) exceed its long term liabilities (SGD1.1M).


Debt to Equity History and Analysis

Debt Level: AJJ is debt free.

Reducing Debt: AJJ has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AJJ has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: AJJ has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 9.5% each year.


Dividend

What is Asian American Medical Group current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AJJ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AJJ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AJJ's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AJJ's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: AJJ is not paying a notable dividend for the Australian market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AJJ's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.0yrs

Average board tenure


CEO

Asian American Medical Group has no CEO, or we have no data on them.


Board Members

Experienced Board: AJJ's board of directors are considered experienced (8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Asian American Medical Group Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Asian American Medical Group Limited
  • Ticker: AJJ
  • Exchange: ASX
  • Founded: 1994
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: AU$11.824m
  • Shares outstanding: 347.75m
  • Website: https://www.aamg.co

Number of Employees


Location

  • Asian American Medical Group Limited
  • Gleneagles Hospital
  • Annexe Block No. 02-37
  • Singapore
  • 258500
  • Singapore

Listings


Biography

Asian American Medical Group Limited provides specialized medical services for liver diseases in Singapore, rest of Asia, and internationally. It operates through Liver, Multi-Speciality, Management and Co...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/24 17:00
End of Day Share Price2021/06/24 00:00
Earnings2021/02/28
Annual Earnings2020/08/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.